Labs Partner with Pharma Companies to Develop New CDx Tests
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.